Indoco Remedies Limited

NSEI:INDOCO Voorraadrapport

Marktkapitalisatie: ₹29.0b

Indoco Remedies Beheer

Beheer criteriumcontroles 3/4

De CEO Indoco Remedies is Sundeep Bambolkar, benoemd in Feb2012, heeft een ambtstermijn van 12.75 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 75.54M, bestaande uit 61.7% salaris en 38.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.18% van de aandelen van het bedrijf, ter waarde ₹ 53.03M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.9 jaar en 14 jaar.

Belangrijke informatie

Sundeep Bambolkar

Algemeen directeur

₹75.5m

Totale compensatie

Percentage CEO-salaris61.7%
Dienstverband CEO12.8yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn7.9yrs
Gemiddelde ambtstermijn bestuur14yrs

Recente managementupdates

Recent updates

Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Oct 27
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

May 24
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Jan 26
Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

Jan 26
Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Sep 16
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

May 21
Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Aug 31
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Jul 04
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Jul 02
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Jun 10
Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Mar 25
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

Mar 09
Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Feb 22
What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Feb 07
Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 17
Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Dec 27
Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

Dec 06
Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Nov 14
What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Analyse CEO-vergoeding

Hoe is Sundeep Bambolkar's beloning veranderd ten opzichte van Indoco Remedies's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

₹321m

Jun 30 2024n/an/a

₹767m

Mar 31 2024₹76m₹47m

₹985m

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹65m₹40m

₹1b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹2b

Jun 30 2022n/an/a

₹2b

Mar 31 2022₹46m₹30m

₹2b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹28m₹20m

₹930m

Dec 31 2020n/an/a

₹734m

Sep 30 2020n/an/a

₹571m

Jun 30 2020n/an/a

₹393m

Mar 31 2020₹18m₹15m

₹241m

Dec 31 2019n/an/a

₹302m

Sep 30 2019n/an/a

₹264m

Jun 30 2019n/an/a

₹111m

Mar 31 2019₹15m₹12m

-₹29m

Mar 31 2018₹16m₹12m

₹412m

Compensatie versus markt: De totale vergoeding ($USD 898.32K ) Sundeep } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 268.55K ).

Compensatie versus inkomsten: De vergoeding van Sundeep is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Sundeep Bambolkar (64 yo)

12.8yrs

Tenure

₹75,540,000

Compensatie

Mr. Sundeep Vasant Bambolkar has been a Joint Managing Director at Indoco Remedies Limited since February 15, 2012. Mr. Bambolkar served as Chief Financial Officer at Indoco Remedies Limited from March 23,...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Suresh Kare
Non-Executive Chairman & Whole time Director61.3yrs₹36.89m4.7%
₹ 1.4b
Sundeep Bambolkar
Joint MD & Executive Director12.8yrs₹75.54m0.18%
₹ 53.0m
Aditi Panandikar
MD & Executive Director12.8yrs₹85.42m6.11%
₹ 1.8b
Pramod Ghorpade
Chief Financial Officer3yrs₹17.38mgeen gegevens
Ramanathan Hariharan
GM of Legal1.9yrs₹5.48mgeen gegevens
Kavita Inamdar
Chief Technical Officerno data₹7.57mgeen gegevens
Ajay Karajagi
President of Sales & Marketingno datageen gegevensgeen gegevens
Rajesh Usgaonker
Chief Marketing Officerno datageen gegevensgeen gegevens
Rajan Saawant
Vice President of Corporate HRno datageen gegevensgeen gegevens
Prashant Pathak
Head of OSDno datageen gegevensgeen gegevens
Abhilash Soral
Executive Vice President of International Business for Regulated Marketsno datageen gegevensgeen gegevens
Hemant Joshi
Senior Vice President of Sales for APIno datageen gegevensgeen gegevens

7.9yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van INDOCO is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.9 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Suresh Kare
Non-Executive Chairman & Whole time Director61.3yrs₹36.89m4.7%
₹ 1.4b
Sundeep Bambolkar
Joint MD & Executive Director20.7yrs₹75.54m0.18%
₹ 53.0m
Aditi Panandikar
MD & Executive Director20.7yrs₹85.42m6.11%
₹ 1.8b
Divakar Gavaskar
Independent Non-Executive Director19.6yrs₹580.00kgeen gegevens
Rajiv Kakodkar
Independent Non-Executive Director17.6yrs₹660.00k0.013%
₹ 3.8m
Anand Nadkarni
Non-Executive Director10.5yrs₹360.00kgeen gegevens
Vasudha Kamat
Non-Executive & Independent Director4.7yrs₹500.00kgeen gegevens
Abhijit Gore
Independent Non-Executive Director4.1yrs₹460.00k0.0054%
₹ 1.6m
Satish Shenoy
Independent Directorless than a yeargeen gegevensgeen gegevens
Ajay Mulgaokar
Independent Directorless than a yeargeen gegevensgeen gegevens

14.0yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van INDOCO zijn ervaren en ervaren (gemiddelde ambtstermijn van 14 jaar).